San Diego-based life sciences equipment maker Illumina said today that it has licensed its next generation sequencing technology to Quest Diagnostics, a provider of diagnostic information services. Financial impact of the deal was not announced by the companies. The two said that Quest will gain "broad rights" to Illumina's sequencing and genotyping technology for use in developing, validating, and offering up molecular laboratory-developed tests for diseases. Quest Diagnostics is a major provider of medical testing services.
Top NewsThursday, January 9, 2014
Illumina Licenses Technology To Quest Diagnostics